The Latest Cardiac and Vascular News
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced that William A. Kozy, retired Executive Vice President and Chief Operating Officer at Becton, Dickinson and Company (“BD”), was elected by the Company’s shareholders to its board of directors during its June 12 […]
REDWOOD CITY, Calif., June 13, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Mark Weinswig will join the Company, and serve in the role of Chief Financial Officer (CFO) effective June 25, 2018. […]
VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that its MyHeart™ platform has been selected as 2018’s “Best New Technology Solution – Drug Development” by MedTech Breakthrough, an independent organization that recognizes the top companies, technologies […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, will host an analyst and institutional investor meeting on Tuesday, June 26, 2018, in New York City from 8:30 a.m. to approximately 10:00 a.m. Eastern Time. The meeting will focus […]
BROSSARD, Quebec, June 12, 2018 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the availability of its first cardio application called HTA. This innovative […]
BOSTON, June 12, 2018 (GLOBE NEWSWIRE) — resTORbio, Inc. (NASDAQ:TORC) today announced that Kerry Russell, M.D., Ph.D., has joined the company as its Vice President of Clinical Development, a newly created position as part of the company’s effort to grow through strategic hires. In the role, Dr. Russell is responsible […]
ALISO VIEJO, Calif., June 12, 2018 /PRNewswire/ — MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA clearance of a new clinical indication for the SOFIA® Catheter (Soft TOrqueable catheter For Intracranial Access) to include contact aspiration technique for successful revascularization among patients with acute ischemic stroke, secondary to intracranial large […]
CAMBRIDGE, Mass., June 12, 2018 /PRNewswire/ — The Cardiovascular Research Consortium (CRC), a nationwide network of community-based cardiology practices, has selected TriNetX’s real-world evidence platform to provide the biopharmaceutical industry with the first-of-its-kind access to extensive cardiology-specific clinical data. The data in combination with TriNetX’s advanced analytics capabilities and on-demand access, will enable […]
ATLANTA, June 11, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announces the publication of our clinical study entitled “Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement” in a peer-reviewed medical journal, the Journal of the American College of Cardiology. The publication reports outcomes from […]
Report: Stryker puts in takeover bid for Boston Scientific JUNE 11, 2018 BY FINK DENSFORD Stryker (NYSE:SYK) has put in a bid as it looks to acquire rival Boston Scientific (NYSE:BSX), according to a new report from the Wall Street Journal. Boston Scientific has not actively responded to the approach, according to the report, which came […]
